Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
| 305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
| 736 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//DICLOFENAC | 13004 |
| 37934 | 1 | CEFROXADINE//BOLUS FOOD//INVEST BIOL BIOMED SUR INBIOSUR CONICET | 73 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CEFROXADINE | authKW | 555093 | 4% | 43% | 3 |
| 2 | BOLUS FOOD | authKW | 431741 | 1% | 100% | 1 |
| 3 | INVEST BIOL BIOMED SUR INBIOSUR CONICET | address | 215870 | 1% | 50% | 1 |
| 4 | INVEST BIOQUIM BAHIA BLANCA INIBIBB CONICET | address | 143912 | 1% | 33% | 1 |
| 5 | ANTIINFLAMMATORY AGENT | authKW | 75082 | 3% | 9% | 2 |
| 6 | PIRPROFEN | authKW | 71955 | 1% | 17% | 1 |
| 7 | CHEMOTHERAPY-TOKYO | journal | 56798 | 7% | 3% | 5 |
| 8 | INVESTIGACION MEDICA INTERNACIONAL | journal | 43653 | 4% | 3% | 3 |
| 9 | NOUVELLE PRESSE MEDICALE | journal | 35558 | 12% | 1% | 9 |
| 10 | FORTSCHRITTE DER MEDIZIN | journal | 30985 | 12% | 1% | 9 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 764 | 59% | 0% | 43 |
| 2 | Medicine, General & Internal | 302 | 30% | 0% | 22 |
| 3 | Medicine, Research & Experimental | 67 | 12% | 0% | 9 |
| 4 | Oncology | 38 | 14% | 0% | 10 |
| 5 | Hematology | 18 | 5% | 0% | 4 |
| 6 | Materials Science, Biomaterials | 3 | 1% | 0% | 1 |
| 7 | Chemistry, Medicinal | 3 | 3% | 0% | 2 |
| 8 | Toxicology | 3 | 3% | 0% | 2 |
| 9 | Microbiology | 1 | 3% | 0% | 2 |
| 10 | Pathology | 0 | 1% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INVEST BIOL BIOMED SUR INBIOSUR CONICET | 215870 | 1% | 50% | 1 |
| 2 | INVEST BIOQUIM BAHIA BLANCA INIBIBB CONICET | 143912 | 1% | 33% | 1 |
| 3 | INQUISUR | 2451 | 1% | 1% | 1 |
| 4 | BIOL BIOQUIM FARM | 713 | 1% | 0% | 1 |
| 5 | BALSEIRO | 291 | 1% | 0% | 1 |
| 6 | ATOM BARILOCHE | 210 | 1% | 0% | 1 |
| 7 | CONICET | 21 | 1% | 0% | 1 |
| 8 | QUIM | 4 | 1% | 0% | 1 |
| 9 | PHARM | 0 | 1% | 0% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CHEMOTHERAPY-TOKYO | 56798 | 7% | 3% | 5 |
| 2 | INVESTIGACION MEDICA INTERNACIONAL | 43653 | 4% | 3% | 3 |
| 3 | NOUVELLE PRESSE MEDICALE | 35558 | 12% | 1% | 9 |
| 4 | FORTSCHRITTE DER MEDIZIN | 30985 | 12% | 1% | 9 |
| 5 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 5281 | 4% | 0% | 3 |
| 6 | CHEMOTHERAPY | 4215 | 7% | 0% | 5 |
| 7 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 3244 | 8% | 0% | 6 |
| 8 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2649 | 5% | 0% | 4 |
| 9 | ACTA THERAPEUTICA | 1739 | 1% | 0% | 1 |
| 10 | PHARMATHERAPEUTICA | 1364 | 1% | 0% | 1 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CEFROXADINE | 555093 | 4% | 43% | 3 | Search CEFROXADINE | Search CEFROXADINE |
| 2 | BOLUS FOOD | 431741 | 1% | 100% | 1 | Search BOLUS+FOOD | Search BOLUS+FOOD |
| 3 | ANTIINFLAMMATORY AGENT | 75082 | 3% | 9% | 2 | Search ANTIINFLAMMATORY+AGENT | Search ANTIINFLAMMATORY+AGENT |
| 4 | PIRPROFEN | 71955 | 1% | 17% | 1 | Search PIRPROFEN | Search PIRPROFEN |
| 5 | ENTERAL TUBE FEEDING | 11360 | 1% | 3% | 1 | Search ENTERAL+TUBE+FEEDING | Search ENTERAL+TUBE+FEEDING |
| 6 | TOLFENAMIC ACID | 5077 | 1% | 1% | 1 | Search TOLFENAMIC+ACID | Search TOLFENAMIC+ACID |
| 7 | TRAUMA PATIENTS | 4543 | 1% | 1% | 1 | Search TRAUMA+PATIENTS | Search TRAUMA+PATIENTS |
| 8 | HUMAN PLASMA | 240 | 1% | 0% | 1 | Search HUMAN+PLASMA | Search HUMAN+PLASMA |
| 9 | HYDROGEN BONDING | 139 | 3% | 0% | 2 | Search HYDROGEN+BONDING | Search HYDROGEN+BONDING |
| 10 | X RAY DIFFRACTION | 43 | 3% | 0% | 2 | Search X+RAY+DIFFRACTION | Search X+RAY+DIFFRACTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |